Barriers to the utilization of thrombolysis for acute ischaemic stroke

Summary What is known and Objective: Thrombolysis is currently the only evidence‐based pharmacological treatment available for acute ischaemic stroke (AIS); however, its current utilization is suboptimal (administered to

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical pharmacy and therapeutics 2012-08, Vol.37 (4), p.399-409
Hauptverfasser:	Eissa, A., Krass, I., Bajorek, B. V.
Format:	Artikel
Sprache:	eng
Schlagworte:	alteplase barriers Biological and medical sciences Brain Ischemia - drug therapy Brain Ischemia - pathology cerebrovascular accident Delivery of Health Care, Integrated - organization & administration Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - therapeutic use Humans Medical sciences Neurology Pharmacists - organization & administration Pharmacology. Drug treatments Professional Role stroke Stroke - drug therapy Stroke - pathology thrombolysis Thrombolytic Therapy - methods Time Factors tissue plasminogen activator Triage - methods Triage - standards Vascular diseases and vascular malformations of the nervous system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Summary What is known and Objective: Thrombolysis is currently the only evidence‐based pharmacological treatment available for acute ischaemic stroke (AIS); however, its current utilization is suboptimal (administered to
ISSN:	0269-4727 1365-2710
DOI:	10.1111/j.1365-2710.2011.01329.x